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Background: Duck circovirus may predispose the host to immunosuppression and may serve as an immunological
trigger for further complicated disease progression. Due to the lack of a cell culture system for propagating DuCV,
little is known regarding the molecular biology and pathogenesis of DuCV. The aim of this study was to describe
the construction and initial in vivo characterization of full-length DNA clones of DuCV (pIC-Mu2DuCV) and its infectivity
under in vivo conditions.
Method: The constructed pIC-Mu2DuCV contained two copies of the whole DuCV genome and an introduced Xho I
restriction enzyme site. Eighty-one 10-day-old conventional ducklings that were free of DuCV were randomly divided
equally into three groups (1, 2 and 3). The ducklings in groups 1, 2 and 3 were inoculated intramuscularly with
pIC-Mu2DuCV, wild-type virus GH01 and PBS, respectively. Subsequently, all of the ducklings were examined clinically,
which were each given a physical condition score, and their rectal temperatures were taken daily during the
experimental period. DuCV genomes in serum samples and in various tissues from all of the ducklings at 0, 1,
3, 5, 7, 10, 15, 21 and 28 DPC were detected by PCR and real-time quantitative PCR, respectively.
Results: The average daily weight gain (ADWG) of group 3 was significantly higher than those of groups 1 and 2, and
the temperature of all ducklings was stable between 41.7 °C and 42.2 °C. The clinical values (physical condition scores)
of groups 1, 2 and 3 were 12.5, 15.6 and 0, respectively. In addition, viremia occurred at 15 and 10 days post-challenge
(DPC) in groups 1 and 2, and antibodies could be detected in these ducklings at 21 and 15 DPC. Proliferation
ability analysis showed that the viral titers of group 1 were lower than those of their parental viruses in group 2.
Conclusion: This study shows that the rescued viruses are not significantly different but exhibit lower pathogenicity
and proliferation ability compared with the parental virus. The results will facilitate future studies on DuCV pathogenesis
and biology.
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The duck circovirus (DuCV) is a member of the genus
Circovirus within the family Circoviridae. The DuCV virion
is icosahedral, non-enveloped, and 15 to 16 nm in diameter
[1]. DuCV was originally reported in two female 6-week-
old Mulard ducks from a German farm; both ducks had a
feathering disorder and poor body condition [1, 2]. The* Correspondence: jiary@sicau.edu.cn; chenganchun@vip.163.com
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unless otherwise stated.virus has since been reported in Hungary [3], Taiwan [4],
the US [5] and Mainland China [6–9]. DuCV has been de-
tected in Muscovy, Mule and Pekin ducks, where it
causes stunting and feather abnormalities. Although
controversial, lymphoid depletion predisposes the host
to immunosuppression, and disease progression is fur-
ther complicated by co-infections with other bacterial
and viral pathogens [2, 10].
DuCV consists of a single-stranded, circular DNA gen-
ome that contains approximately 1988–1996 nucleotides
(nts) and two major open reading frames (ORFs) [1]. ORF1,
denoted the rep gene, encodes the replication-associated
protein, which is required for viral replication initiation.is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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structural and virulence-associated protein that stimulates
the host immune response. The intergenic regions of these
ORFs contain a stem loop, which is considered the site of
viral DNA replication initiation [1, 5].
At present, DuCV is not considered to be directly
associated with a particular disease, although recent
studies have suggested that DuCV partially contributes
to lymphoid depletion [2], may predispose the host to
immunosuppression and may serve as an immunological
trigger for further complicated disease progression [3–7].
Indeed, DuCV-affected ducks exhibited a higher prevalenceFig. 1 Construction strategy of pIC-2DuCV. a Two full-length genomes of D
were ligated into the pUC19 vector to yield pIC-1 and pIC-2, respectively. c
DuCV DNA clone, which was denoted pIC-2DuCV. d pIC-2DuCVand greater loads of other bacterial and viral pathogens
than non-DuCV-affected ducks [1, 11]. However, the re-
sults from the above-mentioned studies do not support a
direct association of DuCV with another pathogen or with
host damage.
Due to the lack of a cell culture system for propagating
DuCV, little is known regarding the molecular biology
and pathogenesis of DuCV. To definitively characterize
diseases associated with DuCV infection, an appropriate
animal model is needed [12]. In addition, reverse genetics
is a powerful tool for addressing these questions [13–15].
Because infections with multiple different genotypes oruCV strain GH01, denoted IC1 and IC2, were amplified. b IC1 and IC2
IC-2 was ligated head-to-tail to pIC-1 to produce a tandem-dimerized
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and isolated form of a specific DuCV that is generated
from a full-length infectious DNA clone is also re-
quired to study the pathology due to a single pheno-
type [15]. To date, no infectious DNA clones of DuCV
in cultured cells or animals have been reported; there-
fore, it is important to construct an infectious DuCV
DNA clone that can be used as a model for studying
the replication and transcription mechanisms of
DuCV as well as for dissecting the structural and func-
tional relationships between host and DuCV genes.
Here, we describe the construction and initial in vivo
characterization of full-length DNA clones of DuCV.
Furthermore, the rescue of a DuCV containing the in-
troduced genetic markers was confirmed by sequen-
cing of viral DNA obtained from ducks experimentally
inoculated with circular DuCV genomic DNA.Fig. 2 Construction strategy of pIC-Mu2DuCV. a Two full-length genomes
overlapping PCR. b IC-Mu1 and IC-Mu2 were ligated into the pUC19 vecto
head-to-tail to pIC-Mu1 to produce a tandem-dimerized DuCV DNA clone,Materials and methods
Ethics statement
The experimental procedures were performed in strict
accordance with the Guidance Suggestions for the Care
and Use of Laboratory Animals and were approved by
the National Institute of Animal Health Animal Care
and Use Committee of Sichuan Agricultural University
(Approval Number 2012–032).Viruses and animals
Duck circovirus strain GH01 (GenBank No. JX499186)
was isolated and maintained at the Institute of Pre-
ventive Veterinary Medicine of Sichuan Agricultural
University. A cloned strain with a genetic marker,
termed RMDV, was obtained and used as the animal-
challenge strain in this study to avoid contaminationof DuCV strain GH01, denoted IC-Mu1 and IC-Mu2, were amplified by
r to yield pIC-Mu1 and pIC-Mu2, respectively. c IC-Mu2 was ligated
which was denoted pIC-Mu2DuCV. d pIC-Mu2DuCV







A 5 i.m. 10-day-old 100 200 -
B 5 i.m. 10-day-old 100 200 -
C 5 i.m. 10-day-old - 200 100
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Ninety-six healthy, 10-day-old commercial ducklings
were obtained from a duck farm that was negative for
DuCV, as detected by PCR.Construction of a DuCV molecular DNA clone
The full-length genome of DuCV strain GH01 was
amplified by PCR using two pairs of primers, namely
IC-1F/IC-1R and IC-2 F/IC-2R (Fig. 1a), and the ampli-
fication products were named IC1 and IC2, respect-
ively. The products were subsequently inserted into a
pUC19 vector (TaKaRa, Dalian, China) that had been
previously digested with Hind III/BamH I or BamH I/EcoR
I, respectively. The resulting constructs were termed
monomeric DuCV DNA pIC-1 or pIC-2, respectively,
and then transformed into Escherichia coli DH5α com-
petent cells (Fig. 1b). The recombinant plasmids were
verified by PCR, restriction enzyme digestion and DNA
sequencing. The full-length IC-2 was excised from pIC-2
by digestion with the BamH I and EcoR I restriction en-
zymes, gel-purified and ligated head-to-tail with pIC-1 to
construct a tandem-dimerized DuCV DNA clone, which
was denoted pIC-2DuCV (Fig. 1c and 1d). pIC-2DuCV
was also confirmed by PCR, restriction enzyme digestion
and DNA sequencing.Introduction of genetic markers into the tandem-dimerized
DuCV DNA clone
An Xho I restriction enzyme site was engineered into
the DuCV genome within the pIC-2DuCV clone to
introduce a genetic marker that would allow discrimin-
ation between the cloned virus and the potential indi-
genous viruses in the subsequent animal study. To
create the unique Xho I site (C′TCGAG; mutation is
underlined), an A-to-G point mutation at nucleotide
position 482 of the IC-2 genome was generated by a





1 27 i.m. 10-day-old
2 27 i.m. 10-day-old
3 27 i.m. 10-day-oldMuF/IC-R1 and IC-F1/IC-MuR) containing the desired
mutations (Fig. 2a). The corresponding region in GH01
was replaced by the fusion PCR product using the Xho I
sites at both ends. The mutation did not change the puta-
tive ORFV1 or its complementary amino acid sequence.
The resulting full-length DNA clones were named IC-
Mu1 and IC-Mu2, respectively (Fig. 2b). All mutations
were confirmed by restriction enzyme digestion and DNA
sequencing. Using the same strategy, IC-Mu1 and IC-Mu2
were ligated to the pUC19 vector to produce a tandem-
dimerized DuCV DNA clone, denoted pIC-Mu2DuCV
(Fig. 2c and 2d).
In vivo transfection of ducklings with the DuCV molecular
DNA clone
To determine whether the plasmid DNA of the dimerized
DuCV or muDuCV clone was infectious when directly
injected intramuscularly into ducklings, fifteen 10-day-old
ducklings were randomly assigned into three rooms of five
animals each, and prior to inoculation, the absence of
DuCV in the ducklings was verified by PCR. The
ducklings were then inoculated intramuscularly with
approximately 100 μg/kg recombinant plasmid DNA
pIC-2DuCV, pIC-Mu2DuCV or pUC19 vector com-
bined with 200 μg/kg Lipofectamine 2000 (Invitrogen,
Shanghai) (Table 1). Blood samples were then collected at
0 (before inoculation), 1, 3, 7, 10, 15, 21 and 28 DPC and
submitted to DuCV detection.
Eighty-one 10-day-old ducklings were divided ran-
domly into two challenge groups (groups 1 and 2) and a
control group (group 3; 27 ducklings in each group) and
were raised separately in different isolation rooms with
individual ventilation systems. The animals received food
and water ad libitum. The group-1 and group-2 ducklings
were inoculated intramuscularly with a defined dose
(0.5 ml × 105 ID50/ml) of pIC-Mu2DuCV, and the
ducklings in the control group were mock-inoculated with
the same volume of PBS using the above-mentionedInoculum and dosage
pIC-Mu2DuCV WT-DuCV PBS
100 μg/kg - -
0.5 ml × 105ID50/ml -
0.5 ml
Fig. 4 Identification of recombinant pIC-Mu2DuCV plasmid by restriction
enzyme digestion. M, wide-range DNA marker (500 ~ 12,000); 1, digested
with Hind III; 2, digested with Hind III and BamH I; 3, digested with BamH
I and EcoR I; 4, digested with Hind III and EcoR I; 5, digested with Xho I; 6,
pUC19 digested with Hind III; 7, pUC19
Table 3 Nucleotide sequences of the primer
Primersa Sequences (5′-3′)b Usage
IC-1F CCCAAGCTTGGAACTGGACCAAC Fragment clone
IC-1R TCCGGATCCGAAAAATCCAAATAC







PD-F TGAACCCGGTGAACTGACC Genetic marker
detection
PD-R ATGCGACGCAGCACCTATC
SYBR-F ACTGACGTTGCCCGGAAGTA Quantitate virus
stock
SYBR-R TCTTCCAATCACGTTGCGTTT
aF denotes forward PCR primer; R denotes reverse transcription or reverse
PCR primer
bItalics and underlines stand for restriction enzyme site
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challenge and at the end of the experiment, all of the
ducklings were weighed, and the average daily weight gain
(ADWG) (kg/day) was determined and expressed as (body
weight at 28 DPC – body weight at 0 DPC)/28. Blood
samples were obtained at 0, 1, 3, 5, 7, 10, 15, 21 and 28
DPC for virological and serological examination. After
challenge, all of the ducklings were examined clinically,
and their rectal temperatures were taken daily during the
experimental period. At each examination point, three
randomly selected ducklings were killed and subjected
to postmortem examinations, determination of any gross
lesions, and pathological examinations.Clinical examination
The ducklings of the above-mentioned DuCV-challenged
groups and of the control group were examined clinically
at 0, 1, 3, 5, 7, 10, 15, 21 and 28 DPC and were each given
a physical condition score. The evaluated clinical signsFig. 3 Identification of the recombinant plasmid pIC-2DuCV by
restriction enzyme digestion. M, wide-range DNA marker (500 ~ 12,000);
1, digested with Hind III; 2, digested with Hind III and BamH I; 3, digested
with BamH I and EcoR I; 4, digested with Hind III and EcoR I; 5, pUC19
digested with Hind IIIincluded the presence of wasting, feathering disorder and
depression. The clinical parameters were scored using a
numeric value ranging from 0 to 2 (0 = normal, 1 =mild,
2 = severe).
Serology for DuCV antibody detection
The presence of specific antibodies against DuCV in
serum samples obtained throughout the study at 0, 1, 3,
5, 7, 10, 15, 21 and 28 DPC was determined by ELISA
using a protocol established by our laboratory (data not
published). ELISA was also used to detect changes in the
DuCV-specific antibodies over time in vivo post DuCV
challenge. Ninety-six-well ELISA plates (Corning, USA)
were coated with optimized prepared Cap peptide solu-
tion (data not published) and incubated at 4 °C over-
night. After washing three times with PBS containing
0.05 % Tween-20 (PBST), the plates were blocked with
1 % bovine serum albumin (BSA) in PBS for 1 h at 37 °C.
Following this incubation, the wells were washed three
times with PBST, duck serum diluted with 1 % BSA-PBST
(1:50) was added, and the plates were incubated at 37 °C
for 1 h. After three washes, as described above, HRP-
labeled goat anti-duck IgG (1:5000) was added, and the
plates were incubated at 37 °C for 1 h. After three add-
itional washes, 100 μL of TMB was added to each well,
and the plates were incubated at 37 °C for 20 min for color
development. The color-development reaction was ter-
minated by adding 100 μL of 2 M H2SO4 to each well,
and the absorbance of each well at a wavelength of
450 nm (OD450 nm) was determined using a microplate
reader (Bio-Rad).Table 4 The results of transfection experiment
Groups DPC
0 1 3 5 7 10 15 21 28
A 0/5a 0/5 0/5 0/5 0/5 0/5 2/5 4/5 5/5
B 0/5 0/5 0/5 0/5 0/5 0/5 2/5 5/5 5/5
C 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
a:Number of DuCV positive/Number of ducklings tested
Fig. 5 Identification of DNA from groups A and B. M, DNA marker; 1,
a digested with Xho I; 2, b digested with Xho I
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Serum samples were collected from all of the ducklings
at 0, 1, 3, 5, 7, 10, 15, 21 and 28 DPC, and DuCV nucleic
acids were detected using the primer pair PD-F/PD-R by
PCR. Briefly, PD-F and PD-R were used to amplify a
774-bp-long product, and viral DNA was extracted from
the positive serum samples using a DNA extraction kit
(Tiangen, Beijing) according to the manufacturer’s in-
structions. The amplification was performed in a 20-μL
reaction mixture containing 10 μL of DNA polymerase
mix (Tiangen, Beijing), 0.4 mM of each primer, 0.4 μL of
extracted DNA and 8.8 μL of H2O and using the following
cycling program: 2 min at 94 °C; 35 cycles of 30 s at 94 °C,
30 s at 62 °C and 30 s at 72 °C; and a final extension step
at 72 °C for 5 min. To differentiate the rescued virus from
the parental virus, restriction enzyme digestion and DNA
sequencing were performed.
Real-time quantitative PCR (qPCR) to detect DuCV nucleic
acids in different tissues
Three experimental ducklings from each group were
sacrificed at 0, 1, 3, 5, 7, 10, 15, 21 and 28 DPC, and
various tissues were collected for DuCV nucleic acid ex-
traction using a DNA extraction kit (Tiangen, Beijing)Table 5 Scored values for clinical condition for ducklings in differen
Sign RMDC
Wasting 13 × 0,12 × 1,2 × 2a
Feathering disorder 18 × 0,9 × 1,0 × 2
Depression 15 × 0,11 × 1,1 × 2
Total median score 12.6b
aThe clinical parameters were scored using a numeric value ranging from 0 to 2 (0
bPairs of treatments with (*) were significantly different with control group (p < 0.05according to the manufacturer’s instructions. To quantify
the number of DuCV genomes in the samples, a qPCR
technique established in this laboratory (data not pub-
lished), using the SYBR-F (5′-ACTGACGTTGCCCGGAA
GTA-3′, position 426-445) and SYBR-F (5′-TCTTCCAAT
CACGTTGCGTTT-3′, position 505-485) primer se-
quences, were used (Table 3). Amplification was per-
formed in a 20-μL reaction mixture containing 10 μL
of iTaq™ Universal SYBR® Green (Bio-Rad, Beijing),
0.4 mM of each primer, 0.4 μL of extracted DNA and
8.8 μL of double-distilled H2O. The thermal profile for
the SYBR Green PCR was 95 °C for 30 s, followed by
39 cycles of 95 °C for 10 s and 60 °C for 15 s. The re-
sults of the qPCR are expressed as the logarithm of
the copies of the DuCV genome per gram of sample
(log copies/gram).
Statistical analysis
Comparisons of a single treatment among the different
challenge groups (using the ADWG, ELISA and qPCR
results) were all performed using nonparametric one-
way ANOVA followed by LSD multiple comparisons.
The statistical analysis of the data was performed using
SPSS for Windows (version 16.0), and P < 0.05 was con-
sidered statistically significant in all cases.
Results
Construction of an infectious viral clone
We first generated two monomeric, full-length DuCV
DNA clones, denoted IC-1 and IC-2, that were derived
from the prototype Sichuan isolate GH01 (Fig. 1a and
1b). Each full-length DuCV genome was inserted into a
pUC19 vector containing a eukaryotic promoter. Hind
III/BamH I and BamH I/EcoR I, which were unique re-
striction sites in the pIC-1 and pIC-2 genomes, respect-
ively, were incorporated at the ends of the genomic
DNA to facilitate the generation of concatemers and
thus mimic the DuCV circular DNA genome. Double di-
gestion of the plasmid DNA of each clone with BamH I
or EcoR I resulted in 2.6-kb, 2-kb, and 4.6-kb fragments.
The 2.6-kb fragment represented the backbone vector,
whereas the 2-kb fragment represented the inserted
monomeric DuCV genomic DNA. The 4.6-kb fragment
consisted of the linearized backbone vector with thet challenge groups and the control group
WT-DuCV PBS
10 × 0,14 × 1,3 × 2 27 × 0,0 × 1,0 × 2
16 × 0,9 × 1,1 × 2 27 × 0,0 × 1,0 × 2
13 × 0,12 × 1,2 × 2 27 × 0,0 × 1,0 × 2
15.6* 0
= normal, 1 = mild, 2 = severe); number of elements × scores
)
Fig. 6 Changes in the rectal temperatures of the ducklings from the different experimental groups. The data are presented as the means ± SD
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quently, the 4.6-kb and 2-kb fragments were ligated in
tandem to generate the pIC-2DuCV clone, and the re-
combinant plasmids were verified by PCR, restriction
enzyme digestion and DNA sequencing (Fig. 3).
A fusion PCR technique using two pairs of primers
(IC-MuF/IC-R1 and IC-F1/IC-MuR) containing the de-
sired mutations was utilized to create the unique Xho I
site (Fig. 2a). The resulting fusion PCR products were
named IC-Mu1 and IC-Mu2, respectively (Fig. 2a and 2b),
and processing was continued using the above-described
technique to produce a tandem-dimerized DuCV DNA
clone, which was denoted pIC-Mu2DuCV (Fig. 2c and
2d). All mutagenesis was confirmed by restriction en-
zyme digestion and DNA sequencing (Fig. 4).
The tandem-dimerized DuCV clones pIC-2DuCV and pIC-
Mu2DuCV are infectious when inoculated into ducklings
The ducklings were inoculated intramuscularly with ap-
proximately 100 μg/kg of pIC-2DuCV or pIC-Mu2DuCV
recombinant plasmid DNA or pUC19 vector combined
with 200 μg/kg Lipofectamine 2000 (Table 1). Blood sam-
ples were then collected at 0 (before inoculation), 1, 3, 7,
10, 15, 21 and 28 DPC and used for DuCV detection.Fig. 7 Comparison of the average daily weight gains for the different expeThe viral nucleic acids in the serum in the challenged
groups were detected at 15 DPC using PCR (Table 4),
and restriction enzyme digestion and DNA sequencing
were performed to differentiate the rescued virus from
the parental virus (Fig. 5). The results from these ex-
periments indicated that the constructed full-length
cDNA clones were infectious and that viable viruses
could be recovered; the rescued virus containing the
genetic marker was named RMDV.
Because the genetic marker that was introduced into
the full-length DNA clones can be used to distinguish
between infections caused by the cloned virus or by a
potential indigenous contaminating virus, we performed
a study to further verify the in vivo infectivity of the
RMDV rescue mutant virus in ducklings. Eighty-one
ducklings were assigned to three groups of 27 ducklings
each, and the ducklings in each group were inoculated
with RMDV, WT-DuCV or PBS.
Clinical examination
No apparent gross lesions were observed in the control
group, but clinical signs characterized by wasting, feath-
ering disorder and depression were observed mainly
from 10 to 28 DPC. The mean clinical score (CS) wasrimental groups. *indicates a statistically significant difference (P < 0.05)
Table 6 Examinations of DuCV in sera of ducklings challenged
experimentally with different DuCV strains at different time-points
post challenge with PCR
Groups DPC
0 1 3 5 7 10 15 21 28
RMDV 0/27a 0/24 0/21 0/18 0/15 0/12 4/9 5/6 3/3
WT-DuCV 0/27 0/24 0/21 0/18 0/15 3/12 7/9 6/6 3/3
PBS 0/27 0/24 0/21 0/18 0/15 0/12 0/9 0/6 0/3
aNumber of DuCV positive/Number of ducklings tested
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DuCV-challenged groups compared with the PBS-
challenged group throughout the study period, but no
significant differences were observed between the
RMDV- and WT-DuCV-challenged groups (P > 0.05).
The detailed CS values are shown in Table 5.
The rectal temperatures of the ducklings in both of
the challenge groups and in the control group did not
exceed 42.2 °C up to the termination of the experiment
(Fig. 6).
As shown in Fig. 7, the ADWG was higher in the
control group than in the challenge groups, and this
difference was statistically significant (P < 0.05). More-
over, no significant difference in ADWG was observed
between the RMDV-challenged group and the WT-
DuCV-challenged group (P > 0.05), which could represent
persuasive proof of the similar virulence of RMDV and
WT-DuCV. The results confirmed similar virulence of
RMDC as WT-DuCV in ducklings, but further demon-
strations are required.
Viremia
To detect viremia, the viral DNA from serum samples
was collected at 0, 1, 3, 5, 7, 10, 15, 21 and 28 DPC andFig. 8 Detection of DuCV-specific antibodies in sera at different time pointinvestigated using routine PCR. Moreover, restriction
enzyme digestion and DNA sequencing were performed
to differentiate the rescued virus from the parental virus
(data not shown). No viremia was detected in the duck-
lings of the control group, whereas ducklings challenged
with RMDV showed viremia from 15 to 28 DPC. In
addition, earlier and more severe viremia was observed
in the WT-DuCV-challenged group compared with the
RMDV-challenged group (Table 6).
Detection of DuCV-specific antibody
ELISAs were used to investigate the level of DuCV-
specific antibodies in the serum of ducklings from the
DuCV-challenged and control groups. As shown in Fig. 8,
DuCV-specific antibodies appeared at approximately 21
DPC in RMDV-challenged ducklings and at approximately
15 DPC in WT-DuCV-challenged ducklings, and the
antibody titers increased slightly. In contrast, no DuCV-
specific antibodies were detected in the control-group
ducklings.
Virus distribution and quantification in different tissues,
as shown by real-time quantitative PCR (qPCR)
DuCV was localized mainly in the bursa of Fabricius
(BF), spleen, liver, kidney, thymus, and Harderian gland
of the ducklings. The earliest time point at which virus
was observed in the serum of RMDV-challenged ducklings
was 15 DPC, which was 5 days later than the earliest time
point at which virus was observed in WT-DuCV-
challenged ducklings; however, the viral loads of
RMDV-challenged ducklings at 15 DPC were lower
than 104 copies/mg. Meanwhile, the viral loads in the
BF of all of the challenged groups were significantly
greater than those of the other tissues (P < 0.05) and
exceeded 104 copies/mg or 105 copies/mg, reachings
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mg in the RMDV-challenged group and 3.25 × 105 ~
5.47 × 105 copies/mg in the WT-DuCV-challenged group).
In addition, no virus was detected in the control group.
The tissue sample qPCR results are summarized in
Table 7.
Discussion
Due to the lack of a cell culture system for propagating
DuCV, many features of the genomic structure, function
and molecular biology of DuCV remain unknown, even
though DuCV was identified more than ten years ago. In
particular, the molecular basis of the pathogenesis of this
virus is unclear.
Reverse genetics is a powerful tool for addressing these
questions, and in this study, we demonstrated the first
generation of an infectious DNA clone of Sichuan isolateTable 7 Quantification and distribution of viral DNA loads in the dif
DPC NO. PMDC GH01
BF Sp Li K T Hg Seb BF Sp
0 1 -a - - - - - - - -
2 - - - - - - - - -
3 - - - - - - - - -
1 4 - - - - - - - - -
5 - - - - - - - - -
6 - - - - - - - - -
3 7 - - - - - - - - -
8 - - - - - - - - -
9 - - - - - - - - -
5 10 - - - - - - - - -
11 - - - - - - - - -
12 - - - - - - - - -
7 13 - - - - - - - - -
14 - - - - - - - - -
15 - - - - - - - - -
10 16 - - - - - - - + -
17 - - - - - - - + -
18 - - - - - - - - -
15 19 + - + - - - + ++ -
20 + + - - - - + ++ +
21 - - - - - - - + +
21 22 ++ + + + + + + + -
23 + - + + - - + +++ +
24 + + - - - - + +++ +
28 25 ++ + + + + + + ++ -
26 + - + + - - + + +
27 + + - - - - + - +
ano detected;+:-104 copies/mg; ++:104 copies/mg;+++:105- copies/mg
bcopies/μLGH01. The main aim of our work was to produce a
tandem-dimerized DuCV DNA clone. We further
inserted an Xho I restriction enzyme site into the
DuCV genome of the pIC-2DuCV clone to introduce a
genetic marker that could be used to discriminate be-
tween the cloned virus and the potential indigenous
viruses in the subsequent animal study. The recombin-
ant pIC-2DuCV and pIC-Mu2DuCV plasmids and the
pUC19 vector were inoculated intramuscularly into
five ducklings. It appeared that both the pIC-2DuCV
and pIC-Mu2DuCV DNA concatemers were replication-
competent when transfected in vivo because they mim-
icked the natural DuCV circular genome. The rescue of
pIC-2DuCV and pIC-Mu2DuCV was then demonstrated
through in vivo animal experiments.
Ideally, the sequence of an infectious clone should be
completely identical to that of the parental virus, but thisferent experimental ducklings
PBS
Li K T Hg Se BF Sp Li K T Hg Se
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
- - - - - - - - - - - -
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Li et al. Virology Journal  (2015) 12:82 Page 10 of 11goal is difficult to achieve in practice because during
clone construction, some mutations will invariably occur
during PCR amplification. In addition, other mutations
have to be introduced for cloning purposes and for dis-
tinguishing the mutant from the parental virus. Thus,
comparing the biological properties of an infectious
clone-derived virus and its parental strain is important.
Subsequent analysis revealed that the rescued and paren-
tal viruses had nearly identical biological characteristics
in terms of clinical features, antigenicity, proliferation,
distribution, and overall infectivity. The genetic marker
that was engineered into the clone was used to confirm
that the progeny virus was derived from the DNA clone
and not from a contaminating virus. The number of
copies of the engineered virus genome increased during
infection, with the highest numbers (8.34 × 104) ob-
served at 21 DPC, and this increase was followed by a
decline, which was similar to the trend observed for the
parental virus (5.47 × 105). The real-time qPCR results
showed that the rescued virus displayed growth kinetics
very similar to those of the parental virus. The titers of
the parental virus were usually slightly higher than the
those obtained for the rescued virus, a result that may
be real and reflect mutations and genetic defects of the
rescued virus, but the differences in titers and replications
were quite small at all times. The virus that was rescued
from ducklings infected with this mutated, full-length
clone had the same growth properties as the parental
virus, which demonstrates that the infectious DuCV clone
is an excellent tool for site-directed mutagenesis and,
importantly, that the recombinant virus generated in
this study is capable of establishing an infection and
displays similar pathogenicity as the parental virus in
the natural host.Conclusion
In conclusion, we constructed a genetically stable and
similarly pathogenic infectious clone of DuCV, which
will facilitate studies of the pathogenesis, host tropism,
replication, and transcription of this virus. This study
shows that the rescued viruses are not significantly dif-
ferent but exhibit lower pathogenicity and proliferation
ability compared with the parental virus. Further study is
needed to explore the replication, host-DuCV interac-
tions, and clinical significance of RMDV and WT-DuCV.
In summary, we report the first demonstration that
cloned DuCV genomic DNA with a genetic marker is
infectious when directly injected into ducklings. In
addition, we confirmed that the clinical signs of the
ducklings injected with RMDV are similar to those of
ducklings injected with WT-DuCV.
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